Introduction
Acute myeloid leukemia is a malignant disease which is characterized by three different features: (1) hematopoietic cells arrest at a certain level of differentiation; (2) progenitor cells continue to proliferate thereby displacing normal hematopoiesis; and (3) immature cells prematurely leave the bone marrow and infiltrate peripheral tissues. 1 For the egress from the bone marrow the leukemic cells have to cross the bone marrow blood barrier, ie a trilaminar assembly of specialized fibroblasts (adventitial cells), a basement membrane (BM) and an endothelial cell layer. For the infiltration of peripheral tissues the leukemic cells have to attach to and traverse the blood vessel wall in the opposite direction and migrate into the perivascular stroma. Like tumor cell metastasis these traffics depend on the enzymatic modification of extracellular matrix (ECM) components and the BM, to which matrix metalloproteinases (MMPs) are postulated to contribute.
The MMP family consists of 13 structurally and functionally related proteolytic enzymes and their number is still growing. [2] [3] [4] MMPs can be classified according to substrate specificity: two of the enzymes with molecular weights of 72 kDa (MMP-2) and 92 kDa (MMP-9) are subclassified as type IV collagenases/gelatinases, since they preferentially digest denatured collagens (gelatin) and native collagen type IV, the major component of BMs.
The regulation of MMP activity is complex and occurs at various levels: (1) MMPs are secreted as inactive proenzymes which require enzymatic cleavage of a propeptide. (2) MMP activity is inhibited by the stoichiometric interaction with specific tissue inhibitors of metalloproteinases (TIMP-1, -2 and -3). Hence, the balance of activated MMPs and TIMPs is of fundamental importance for ECM remodeling and local degradation of BM, since it determines net proteolytic activity. Disturbance of this equilibrium seems to be involved in tumor cell metastasis [5] [6] [7] [8] and may also influence the premature egress of leukemic cells from the bone marrow. (3) At the transcriptional level, MMP and TIMP gene expression is cell type specific and modulated by many different biologically active agents, such as growth factors, cytokines, hormones, differentiation inducers and tumor promoters. For example, tumor necrosis factor-␣ (TNF-␣), interleukin-1 (IL-1), epidermal growth factor (EGF) and the phorbol ester 12-O-tetradecanoylphorbol-13 acetate (TPA) have been described to induce 92 kDa gelatinase in many cell lines [9] [10] [11] [12] [13] [14] (for a review see Ries and Petrides). 15 Increased levels of MMP expression are found in cells of various malignant tumors often correlating with the metastatic potential of these cells. 5, 16, 17 Recently, the causal relationship between MMP-9 production and metastasis has been shown in a rodent tumor model system, by transfecting a MMP-9 expression vector into tumorigenic but non-invasive rat cells, thereby conferring metastatic behavior to these cells. 18 MMP-9 is produced in normal leukocytes, where it is thought to enable these cells to leave the blood stream and infiltrate peripheral tissues in order to carry out their immunological function at the sites of inflammation. [19] [20] [21] [22] For example, neutrophil granulocytes store presynthesized MMP-9 in granules and release it rapidly after stimulation with interleukin-8 (IL-8) or TPA. 23 Monocytes, on the other hand, also release MMP-9 after stimulation with TPA but are not able to store the enzyme. 24 Interestingly, MMP-9 release is also observed in leukemia cell lines as well as in ex vivo cells from leukemia patients. 25, 26 Recently, we described constitutive and stimulated MMP-9 secretion to be regulated by autocrine stimulation with TNF-␣ in HL-60 (FAB-M2) leukemic cells. 9 In this study, we used the cell line NB4, which is different from HL-60 cells in that these cells carry the t(15/17) chromosomal translocation, and is therefore classified as acute promyelo-cytic leukemia (APL) (French-American-British classification M3 (FAB-M3)). 27 We investigated the production of MMP-9 and TIMP-1 under the influence of TNF-␣ and TPA as well as anti-TNF-␣ and specific anti-TNF-receptor MoAbs in NB4 cells.
Materials and methods

Reagents
All chemical reagents were purchased from Sigma (Munich, Germany) unless otherwise stated. Recombinant human TNF-␣ (rhTNF-␣) and IgG monoclonal antibodies to TNF-␣ (F(ab′) 2 , No. 195F4) were gifts from Knoll AG (Ludwigshafen, Germany). Antagonist MoABs against TNF-R1 (MAB225) and TNF-R2 (MAB226) were from R&D Systems (Wiesbaden, Germany) and the non-specific IgG control antibodies were a gift from Dr A Fontana (Zurich, Switzerland).
Cell culture NB4 cells were a gift of M Lanotte (INSERM, Paris, France). 27 The cells were grown and maintained without serum in RPMI-1640 medium supplemented with 2 mM L-glutamine and 1% (v/v) Nutridoma SP (Boehringer Mannheim, Mannheim, Germany). The cells were seeded with a density of 2-10 × 10 5 and incubated at 37°C in a humidified air atmosphere in the presence of 5% CO 2 .
Zymographic analysis and SDS-PAGE Gelatinolytic activity in cell culture supernatants was determined by zymography with sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) (LKB/Pharmacia, Uppsala, Sweden). This technique was performed on horizontal ultrathin gels (125 × 250 × 0.5 mm) with a 6-20 % (w/v) polyacrylamide gradient. Gels were polymerized on GelBond PAG film (FMC, Rockland, ME, USA), according to the method of Gö rg et al 28 with the modification that gelatin type I at a final concentration of 1.5 mg/ml was copolymerized. Samples were run under nonreducing conditions without prior boiling. Electrophoresis was carried out at 5°C with a maximum voltage of 600 V and a maximum current of 40 mA for 2.5 h. After electrophoresis, gels were washed three times for 20 min in 2% Triton X-100 to remove SDS and to allow proteins to renature. The gels were then incubated in buffer containing 50 mM TRIS·HCl pH 7.5, 5 mM CaCl 2 , 1 M ZnCl 2 and 0.01% (w/v) NaN 3 overnight at 37°C. The zymograms were then stained with 0.4% (w/v) Coomassie Blue in 35% (v/v) ethanol, 10% (v/v) acetic acid and destained in the same solution without the dye. Gelatinase activity was indicated by clear zones of gelatin lysis against a blue background. This method allows the detection of the total amount of secreted gelatinase, because the enzyme is separated from cosecreted inhibitors during electrophoresis and latent proezymes are activated in the gel during treatment with detergent.
For normal SDS-PAGE no gelatin was copolymerized into the gel and the samples were boiled in the presence of reducing agents prior to loading on the gel. After electrophoresis gels were stained with silver according to the method of Heukeshoven and Dernick. 29 
Enzyme purification
All purification procedures were carried out at 4°C. For microsequence analysis of constitutively released gelatinase, 2.8 l of NB4-conditioned medium were concentrated 13-fold by an Amicon Diaflo apparatus fitted with a YM-10 membrane (Amicon, Beverly, MA, USA) in the presence of azide. The material was then applied to a gelatin Sepharose column (1.5 × 10 cm) (Pharmacia, Freiburg, Germany) equilibrated with 50 mM TRIS·HCl, 400 mM NaCl, 5 mM CaCl 2 , 0.02% (v/v) Brij 35, pH 7.5. After the column had been washed with the same buffer, gelatin binding proteins were eluted with 1.5 M NaCl and 5% (v/v) dimethylsolfoxyde (DMSO) in column buffer and subsequently desalted by diafiltration. In order to avoid autodegradation of the proteinases during further purification and concentration ethylenediaminetetraacetic acid (EDTA) and phenantroline, 2 mM each, were added to the eluate and loaded on to a smaller gelatin Sepharose column (0.9 × 1 cm). Three ml eluates were obtained, diafiltrated and concentrated with a Centricon-10 concentration device (Amicon) to a final volume of 200 l and stored at −20°C.
N-terminal amino acid sequence analysis
Protein containing samples were separated by SDS-PAGE in 10% polyacrylamide gels and electroblotted on to glass fiber membranes (Glassybond, Biometra, Gö ttingen, Germany) as described. 30 Coomassie Blue stained protein bands were cut out and sequenced in an Applied Biosystems (Foster City, CA, USA) 477A gas phase sequencer equipped with a 120A PTH analyzer.
RNA isolation
Total RNA was isolated according to a modified method of Chomczynski and Sacchi. 31 Briefly, up to 5 × 10 6 cells were centrifuged and lysed in 500 l of solution D (4 M guanidinium thiocyanate, 25 mM sodium citrate pH 7.0, 0.5% (w/v) sarcosyl, 14.5 mM dithiothreitol). Subsequently 50 l of 2 M sodium acetate pH 4.0, 500 l water saturated phenol and 100 l CIA (chloroform:isoamylic alcohol, 24:1) were added with brief mixing after every step. The emulsion was kept on ice for 15 min and phases were separated by centrifugation. RNA from the aqueous phase was precipitated with isopropanol, centrifuged and redissolved in 300 l of solution D, from where it was recovered by a second precipitation. The RNA was washed with 75% (v/v) ethanol, dissolved in diethylpyrocarbonate treated water and stored at −20°C.
Northern blot analysis
For Northern analysis of MMP-9, TIMP-1 and TNF␣, 10 g of RNA were glyoxylated and subjected to electrophoresis in a 1% (w/v) agarose gel with 10 mM sodium phosphate buffer pH 6.6. 32 RNA was transferred to nylon membranes (Hybond-N; Amersham, Braunschweig, Germany) and immobilized by baking at 80°C for 2 h. The blots were prehybridized in 50% (v/v) formamide, 5 × Denhardt's solution, 6 × saline sodium phosphate EDTA (SSPE), 0.5% (w/v) SDS and 100 g/ml denatured salmon sperm DNA at 48°C for 2 h and hybridized overnight to radiolabeled DNA probes. Random primed labelling of the probes was performed with ␣-32 P-dCTP using the Rediprime random primed DNA labelling system (Amersham). The blots were washed for 15 minutes in 1 × saline sodium citrate (SSC), 0.1% (w/v) SDS followed by two more stringent washes at 50°C in 0.2 × SSC, 0.1% (w/v) SDS.
The following DNA probes were used in this study: a 2. For the quantitative evaluation of autoradiograms a Fuji Bas 1000 phosphoimager and the TINA 2.08e program were used. To ascertain that the differences in transcript expression were not due to differential loading of RNA, each blot was stripped in 5 mM Tris·HCl pH 8.0, 2 mM EDTA 0.1 × Denhardt's solution at 70°C for 1 h and rehybridized with the GAPDH probe. The mRNA detected in each lane was standardized against the corresponding GAPDH signal.
Determination of TNF-␣ concentration by enzymelinked immunosorbent assay (ELISA)
Soluble TNF-␣ antigen was measured in cell culture supernatants using a sandwich ELISA with the same MoABs to TNF-␣ as were used for the neutralization experiments.
Flow cytometric analysis
Cell surface expression of TNF-receptors TNF-R1 and TNF-R2 on NB4 cells was assessed by indirect immunofluorescence and subsequent flow cytometry. Cells were washed in cold PBS and incubated with either MAB225 (anti-TNF-R1) or MAB226 (anti-TNF-R2) (both from R&D Systems), diluted in PBS/10% FCS for 30 min at 4°C. After a single washing cells were incubated with a goat-anti-mouse IgG-FITC-conjugated antibody (Sigma, Deisenhofen, Germany) for another 30 min at 4°C. After a final washing cells were analyzed using a Cytoron flow cytometer and the ImmunoCount II analysis program. Omitting of the primary antibody was used as negative control for the detection of nonspecific fluorescence, since experiments with isotype-matched irrelevant control antibodies yielded similar results (not shown).
Results
Identification, purification and partial structural characterization of MMP-9 and TIMP-1 in NB4 conditioned medium When we cultured NB4 cells under serum-free conditions, they constitutively released two gelatinolytic activities with molecular weights of about 100 and 200 kDa into the medium, as determined by gelatin zymography (Figure 1a , left lane). For further characterization these activities were purified by gelatin Sepharose affinity chromatography and the enzyme preparation showed the same gelatinase pattern as the conditioned medium (data not shown). SDS-PAGE analysis of the same material, however, showed two bands with apparent molecular weights of 98 kDa and 30 kDa, respectively, whereas the 200 kDa band was no longer present ( Figure 1a ,
Figure 1
Zymographic determination of gelatinase release, purification of MMP-9 and TIMP-1 and sequence analysis. (a) NB4 cells were cultured under serum-free conditions. Conditioned medium was analyzed for gelatinolytic activity using gelatin-SDS-PAGE in ultrathin gradient gels (zymography). Gelatinolytic activity was purified by gelatin Sepharose affinity chromatography and analyzed by SDS-PAGE. Protein bands were visualized by silver staining. (b) After separation on SDS-PAGE and electroblotting the purified 98 and 30 kDa protein bands were subjected to micro sequence analysis. The partial N-terminal amino acid sequences obtained were compared with those of MMP-9 from fibrosarcoma cells 10 and TIMP-1 from fetal lung fibroblasts. 33 right lane). This indicates that the 200 kDa gelatinolytic activity may be a dimer of the 98 kDa enzyme. The N-terminal amino acid sequence of both the 98 kDa and the 30 kDa proteins was determined (Figure 1b ) and found to be identical to those of pro-MMP-9 and TIMP-1, respectively.
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Thus we showed, that NB4 cells constitutively released pro-MMP-9, which is complexed with TIMP-1 and that this complex is stable under the conditions of enzyme purification.
Constitutive and stimulated expression of MMP-9, TIMP-1 and TNF-␣ Northern blot analyses revealed constitutive expression of MMP-9, TIMP-1 and TNF-␣ genes (Figure 2) . Addition of TPA (10 ng/ml) elevated MMP-9, TIMP-1 as well as TNF-␣ expression. Stimulation was 17-fold in the case of MMP-9, 13-fold for TIMP-1 and 1.8-fold for TNF-␣ after 24 h of incubation. Incubation of NB4 cells with TNF-␣ led to a dose-and time-dependent increase of steady-state MMP-9 mRNA levels (Figure 3a and b) . Maximal induction was five-fold at 50 ng/ml TNF-␣ after a 48 h incubation. TIMP-1 expression was not influenced by exogenously added TNF-␣ during a 4 day incubation period (Figure 3a and b) . In addition, we were able to show by ELISA, that NB4 cells released TNF-␣ into the Stimulation of MMP-9, TIMP-1 and TNF-␣ gene expression by TPA. NB4 cells were incubated in the absence (control) or presence of 10 ng/ml TPA (TPA) for 48 h. Total RNA was subjected to Northern analysis as described in Materials and methods subsequently using MMP-9, TIMP-1, TNF-␣ and GAPDH probes. The autoradiograph shown is one representative of triplicate cultures. The GAPDH signal serves as a control for RNA loading. The sizes of the mRNAs are indicated on the right. medium under constitutive and TPA stimulated conditions ( Table 1) . Addition of TPA increased the concentration of soluble TNF-␣ protein to varying extents, depending on the incubation time. However, after 48 h, ie at the timepoint when mRNA was prepared for Northern analysis, the result from the ELISA also showed an only moderate increase of the TNF-␣ concentration from 65 to 83 pg/ml.
Influence of neutralizing anti-TNF-␣ antibodies on the constitutive and stimulated expression of MMP-9
To examine the role of endogenously produced TNF-␣ in basal and TPA evoked MMP-9 production in NB4 cells neutralizing monoclonal anti-TNF-␣ antibodies were added to the cells. In the presence of 10 g/ml of the antibodies the MMP-9 mRNA level was reduced to 76% of the level in untreated control cells (Figure 4a and b) . These antibodies completely blocked the increase of gelatinase expression induced by exogenous TNF-␣, proving their neutralizing effect. The TPA evoked MMP-9 expression was also decreased by the addition of anti-TNF-␣ MoAbs. Inhibition was 43 % as compared to cells treated with TPA alone after a 24 h incubation. The MoAbs had no effect on TIMP-1 expression, either in untreated or in TNF-␣-or TPA-stimulated cells (Figure 4a and c).
Cell surface expression of TNF-receptors 1 and 2 NB4 cells were analyzed for the presence of TNF-R1 and TNF-R2 by FACS analyses using the same antibodies that had been used for the blocking experiments. Ninety-two percent of the cells were found to be positive for TNF-R1 and 92% for TNF-R2 ( Figure 5 ). Similar results were obtained with the TNF-R1- /ml/well) were seeded in multiwell plates (Nunc, Roskilde, Denmark) under serum-free conditions either in the absence (control) or in the presence of 10 ng/ml TPA. After incubation for the time periods indicated the cell density was determined, conditioned media were harvested and the TNF-␣ concentration therein was measured by ELISA. Mean values of duplicate cultures are shown.
specific MoAB H398 34 and the TNF-R2-specific MoAB 80M2, 35 respectively (Dr M Grell, personal communication).
Influence of blocking antibodies against TNF-receptor 1 and 2 on the constitutive expression of MMP-9 and TIMP-1
In order to find out which of the two receptors known to mediate TNF-␣ signalling is involved in the autocrine regulation of MMP-9 gene expression, we used MoABs that selectively block TNF-R1 (anti-TNF-R1) or TNF-R2 (anti-TNF-R2), respectively. NB4 cells were treated for 48 h with either anti-TNF-R1 or anti-TNF-R2, a combination of both as well as control antibodies, both in the presence and absence of exogenous TNF-␣. In the absence of exogenous TNF-␣ (black bars in Figure 6 ), the steady-state MMP-9 mRNA level when compared to untreated control was reduced to 84% by anti-TNF-R2, to 45% by anti-TNF-R1 and to 43% by the combination of both antibodies, respectively, whereas control antibodies had no effect. In the presence of exogenous TNF-␣ (white bars in Figure 6 ), MMP-9 gene expression was reduced to 69% by anti-TNF-R2, to 34% by anti-TNF-R1 and to 30% by the combination of both antibodies, respectively, while addition of control antibodies led to an 18% stimulation. These data demonstrate that the stimulation of MMP-9 gene expression by endogenously produced and exogenous TNF-␣ is mainly but not exclusively mediated by TNF-R1.
Discussion
When we analyzed NB4 conditioned medium by gelatin zymography we found two gelatinolytic activities with molecular
Figure 4
Effects of anti-TNF-␣ antibodies on basal and stimulated expression of MMP-9 and TIMP-1. NB4 cells, unstimulated (control) or stimulated with either 50 ng/ml TNF-␣ (TNF-␣) or 10 ng/ml TPA (TPA) were cultured in the presence or absence of 10 g/ml neutralizing monoclonal antibodies against TNF-␣ (anti-TNF-␣) for 48 h. Cells were harvested and MMP-9 and TIMP-1 gene expression was determined by Northern analysis. GAPDH probe was used as a control for RNA loading. 
Figure 5
Flow cytometric analysis of TNF-R1 and TNF-R2 surface expression on NB4 cells. Cells were incubated with either anti-TNF-R1 or anti-TNF-R2 MoABs, washed and incubated again with goat anti-mouse IgG-FITC-conjugated antibodies in order to detect the binding of the receptor-specific antibodies. Omitting of the primary antibodies was used to exclude non-specific binding of antibodies to the cells (control).
masses of 98 and 200 kDa, respectively. After purification on gelatin sepharose affinity chromatography and microsequencing the 98 kDa gelatinase revealed the same N-terminal sequence as the latent proenzyme form of MMP-9. 10 Ries et al 36 have recently described that HL-60 cells release a 94 kDa as well as a C-terminally truncated 63 kDa form of pro-MMP-9, which both lack 8 amino acid residues at their N-terminus. The sequence we obtained for the 98 kDa protein did not show N-terminal modifications in pro-MMP-9 from NB4. Although both cell lines are closely related, HL-60 cells represent a myeloblastic leukemia (FAB-M2), 37 whereas NB4 is characterized as a promyelocytic leukemia cell line (FAB-M3) carrying the t(15/17) chromosomal translocation, which is pathognomonic for APL. 27 This may explain the differences observed in MMP-9 modification in both cell lines.
The high molecular weight gelatinolytic activity we found is most probably a covalent homodimer of the 98 kDa pro-MMP-9 as described by Goldberg et al. 38 This interpretation is supported by our finding that this complex could only be detected when NB4 conditioned medium or purified gelatinase preparations were separated on gelatin SDS-PAGE performed without prior reduction of the samples, but disappeared when samples had been reduced before electrophoresis in normal SDS-PAGE.
Figure 6
Effects of blocking antibodies against TNF-R1 (anti-TNF-R1) and TNF-R2 (anti-TNF-R2) and the combination of both on the expression of MMP-9. NB4 cells were incubated without antibody (control), with anti-TNF-R1, anti-TNF-R2 (50 g/ml each), a combination of both antibodies or control antibodies either in the absence or presence of exogenous TNF-␣ (10 ng/ml) for 48 h. Cells were harvested and MMP-9 gene expression was determined by semiquantitative Northern analysis as described in Materials and methods. The bars represent the result of densitometric quantifications of Northern blots and have been normalized with the GAPDH signal from the appropriate samples. Mean values of duplicate cultures are shown.
Figure 7
Model of an autocrine TNF-␣ loop for the stimulation of MMP-9 expression in NB4 leukemic cells. MMP-9 expression is upregulated by TNF-␣, which is constitutively released from the cells. Exogenously added TNF-␣ exerts the same effect. Anti-TNF-␣ or anti-TNF-R1 antibodies block the autocrine effect of the cytokine and thereby reduce the expression level of MMP-9. The constitutive TIMP-1 expression is regulated independently of TNF-␣. Thus, autocrine regulation with TNF-␣ shifts the balance between pro-MMP-9 and TIMP-1 towards enhanced proteolytic potential in the environment of the cells.
The purification of MMP-9 led to the copurification of a 30 kDa non-gelatinolytic protein. The N-terminal amino acid sequence we obtained was identical to that of TIMP-1 from fetal lung fibroblasts and HL-60 cells. 33, 36 Pro-MMP-9 has been reported to form a complex with TIMP-1 immediately after secretion into the extracellular milieu. 39 This complex is stable under the conditions of gelatin Sepharose affinity chromatography and does not inhibit the enzyme's binding to immobilized gelatin, but is separated during SDS-PAGE. This shows that NB4 cells constitutively release TIMP-1. Since net proteolytic activity is thought to depend on the balance between the levels of MMP-9 and TIMP-1, we investigated the transcriptional regulation of both genes under the influence of TNF-␣ and TPA, which have been shown to stimulate gelatinase production in a variety of cell systems. 9, 11, 40, 41 In accordance with a recent publication of Gianni et al 42 we found NB4 cells to constitutively express TNF-␣ on the mRNA level. However, TNF-␣ is known to be produced as a membrane bound precursor, which requires proteolytic activation. 43 In order to find out whether TNF-␣ is released from NB4 cells, we determined soluble TNF-␣ in NB4 conditioned medium, which is a prequisite for the autocrine regulation we describe here.
We found that TPA strongly induced MMP-9 as well as TIMP-1 gene expression to a similar extent. This means, that the non-physiological stimulus TPA leads to a coordinate overexpression of the gelatinase and its inhibitor, which eventually should not be able to increase net proteolytic activity in the cell's microenvironment. Coregulation of MMP-9 and TIMP-1 has been described not only for TPA but also for IL-1 and TNF-␣ in various malignant cell lines as well as cells of hematopoietic origin. 26, 39, 44 Like TPA, TNF-␣ also upregulated the expression of MMP-9, but had no influence on TIMP-1 mRNA level in NB4 cells. This is in accordance with the finding of Mackay et al 44 who described a similar effect in a lung carcinoma cell line. The difference in the regulation of MMP-9 and TIMP-1 by TPA and TNF-␣ could be explained by the observation that TPA acts by inducing the binding of the AP-1 complex to a TPA responsive element (TRE), which is present in the MMP-9 as well as the TIMP-1 promoter. In contrast, the stimulatory effect of TNF-␣ is known to be mediated by nuclear factor B (NF-B), a binding site for which is present in the MMP-9 promoter but not in the promoter of TIMP-1.
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Since we found NB4 cells to constitutively express TNF-␣, we hypothesized that this cytokine may be involved in the autocrine regulation of constitutive MMP-9 expression in NB4 cells, as we previously described for the release of MMP-9 from HL-60 cells. 9 In contrast to the findings in HL-60, TPA led only to a moderate increase of TNF-␣ expression in NB4 cells, both in the mRNA and protein levels.
Thus, we used neutralizing MoAbs against TNF-␣ to antagonize constitutively secreted TNF-␣. We found basal as well as TPA evoked MMP-9 expression reduced in the presence of the MoAbs. The inhibitory effect of anti-TNF-␣ suggests that the basal as well as the TPA evoked MMP-9 expression is maintained by the autocrine action of constitutively secreted TNF-␣. However, even the high excess of anti-TNF-␣ antibodies we used did not completely abrogate gelatinase expression and was less efficient than anti-TNF-R1, although it completely abolished the effect of exogenous TNF-␣ when added in combination with the cytokine. This may be due to limited half-life time of the F(ab′) 2 -anti-TNF-␣-antibodies under cell culture conditions, the continuous delivery of newly released TNF-␣ by the cells, a possible intracrine action of TNF-␣, or, most likely, to the presence of endogenous stimulants other than TNF-␣. Anti-TNF-␣ had no effect on TIMP-1 expression. This is not surprising, since exogenous addition of TNF-␣ also failed to induce TIMP-1.
FACS analysis showed that a high percentage of NB4 cells possess TNF-R1 and TNF-R2 on their surface. Our experiments with blocking antibodies against each of the two TNF receptors show that the stimulation of MMP-9 gene expression by endogenous TNF-␣ is mainly mediated by the 55 kDa TNF-R1, a receptor that has been reported to induce NF-B after stimulation by its ligand. 46 This interpretation is supported by the fact that the promoter of TIMP-1 lacks an NF-B binding site (see above) and thus cannot be switched on by TNF-␣ in our system.
Our experiments present evidence for the existence of an autocrine TNF-␣-loop in the APL cell line NB4, that selectively upregulates MMP-9 expression via the TNF-R1/NF-B pathway, which has no influence on the expression of TIMP-1 ( Figure 7 ). Since it has been reported, that TNF-␣ levels are significantly increased in the serum of AML patients 47 and that TNF-␣ is constitutively expressed in myeloid leukemias, 48 the TNF-␣-induced MMP-9 expression may be important in the pathophysiology of the premature egress of leukemic cells from the bone marrow and their dissemination into peripheral tissues.
